drugset / Trial / NCT03121261

The Effect of Local Anesthetic and Clonidine on the Cutaneous Silent Period During Spinal Anesthesia

NCT03121261

Phase 4 Active not recruiting 60 enrolled University Hospital Dubrava
RandomizedParallel-groupDouble-blindTreatment

Summary

The cutaneous silent period is a non-invasive technique that gives insight into the function of thin A delta fibers and as such can be a complement to conventional electrophysiological methods used to study the peripheral nerves. Clonidine is a selective partial agonist of the alpha-2 receptors which, added intrathecally to levobupivacaine, enhances the effect of a local anesthetic, prolongs sensory and motor block during local anesthesia and extends the length of post-operative analgesia. It is believed that clonidine achieves this effect by activating the postsynaptic alpha-2 receptors in the gelatine substance of the spinal cord and blocking the conduction of A-delta and C fibers. The aim of the study is to examine functional changes of Aδ - fibers during the application of spinal anesthesia by measuring the cutaneous slinet period and compare the effect of intrathecal administration of a combination of local anesthetic and clonidine in the quiet skin period in relation to the application of local anesthetic only.

Timeline

Start
2017-05-01
Primary completion
2027-09
Completion
2028-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified 50 ug Intrathecal
Background Levobupivacaine Other / unclassified 15 mg Intrathecal

Indications

No indication recorded.